Salen for sale the Japanese anteojos that promise to correct the myopia without surgery

Receive a diagnostic of myopia equivale a preparatory para to use anteojos o contact straps toda la vida, o someterse a cirugías to correct. The equivalent, following the company japanese Kubota, dedicated to the vision camp, which hopes to start selling in Taiwan, Singapore, Hong Kong, Thailand and Malaysia have announced plans to conclude with a statement on the posterity of the island which causes this condition of the soul can not be distinguished with nitidez the objects objects.

Loose Anteojos Kubota is a prototype that hopes to launch the commercial scale af Asia in the second half of 2021. El portable is used in front of the islands, as a common gaff, from 60 to 90 minutes per day to correct the refraction error that causes the defect. Los anteojos proyectan una foca image foca dede la la unidad hacia la retina del usuario which works as an accelerator that, following a laboratory study, “Reduce the length of the egg” that goes from the cornea to the retina and hace that distant objects are vean borrosos.

For now more details are known, between these key questions as how many days, how many months have we used the device to control myopia, how many times during the correction effect. While launching a clinical trial in the United States, the company is available to commercialize the antees “first in Asia, which has a huge amount of people”, Dijo in a communication Ryo Kubota, president of the company.

In the population of 20 years or less, 96% of the people of South Korea, 95% of Japan, 87% of Hong Kong, 85% of Taiwan and 82% of Singapore suffer from myopia, just read the document. There are 2,560 million people worldwide with this difficulty and it is estimated that in 2030 habrá unos 3,400 millone.

The myopia progresses to the middle as the longitudinal edge of the eye increases, until the tenth year, when se detiene. But increase the burden of deserrollar enfermedades graves for the vista as the myopic maculopathy, retinal detachment and glaucoma. Kubota will start clinical trials of its predecessors in 2020 and will also be rolling out — since there will be a resumption of studies — a similar device to the contact lenses to control the myopia.

MORE ABOUT THIS THEME:

Why the myopia should not increase in Europe and the United States

Come the excess of pants during the pandemic affects the health of the islands

Vaunt, the intelligent antees that project images in the user’s retina